Holen Sie sich die Stockscreener-App
5.0358
0.20%
0.0358
Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten
What drives Precision BioSciences Inc. stock priceDynamic investment opportunities - PrintWeekIndia
What analysts say about Precision BioSciences Inc. stockOver 200% growth - Autocar Professional
Precision BioSciences shares climb after FDA grants orphan drug status - MSN
Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD - Contract Pharma
Precision Biosciences’ PBGENE-DMD gains US orphan drug designation - BioWorld MedTech
Precision BioSciences stock rises after FDA grants orphan drug status By Investing.com - Investing.com Canada
FDA Grants Orphan Drug Designation to Precision BioSciences' PBG - GuruFocus
FDA grants orphan drug status to Precision BioSciences’ DMD treatment - Investing.com Australia
FDA grants orphan drug status to Precision BioSciences’ DMD treatment By Investing.com - Investing.com South Africa
Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Yahoo Finance
Precision BioSciences Inc. Stock Analysis and ForecastFree Capital Growth Strategies - jammulinksnews.com
Precision BioSciences Secures Orphan Drug Designation for DMD Treatment, DTIL Stock News - AInvest
Precision BioSciences Duchenne muscular dystrophy treatment gets orphan status - TipRanks
Precision BioSciences gets FDA orphan drug designations for DMD treatment By Investing.com - Investing.com Canada
Precision BioSciences reports promising DMD gene editing results By Investing.com - Investing.com Canada
Precision BioSciences Highlights New Preclinical Data for PBGENE-DMD Further Supporting Advancement of Novel Gene Editing Approach for the Treatment of Duchenne Muscular Dystrophy Towards Clinic - Business Wire
How Precision BioSciences Inc. stock performs during market volatilityFree Market Sentiment Analysis - Newser
Precision Bio's DMD Therapy Gets Rare Pediatric Status, But Stock Slides; Retail Crowd Sees ‘Good Risk-Reward’ - MSN
Why Precision BioSciences Inc. stock attracts strong analyst attentionPortfolio Boosting Stock Alerts - Newser
What makes Precision BioSciences Inc. stock price move sharplyTriple Digit Return Forecasts - Newser
(DTIL) Proactive Strategies - news.stocktradersdaily.com
Precision Biosciences CFO Sells Shares to Cover Tax Obligations - TradingView
Precision BioSciences, Inc.(NasdaqCM: DTIL) added to Russell 3000E Value Index - MarketScreener
Insider Buying: Kevin Buehler Acquires Shares of Precision BioSciences Inc (DTIL) - GuruFocus
Precision Biosciences director Brown buys $6963 in DTIL stock - Investing.com
Precision BioSciences stock jumps after FDA grants rare pediatric designation By Investing.com - Investing.com UK
A startup banks $66M to pursue ‘inclusive precision medicine’ - BioPharma Dive
precision biosciences reports voting outcomes at annual shareholder meeting By Investing.com - Investing.com Australia
precision biosciences reports voting outcomes at annual shareholder meeting - Investing.com
Precision BioSciences Holds Annual Stockholder Meeting - TipRanks
Precision BioSciences (DTIL): Rating Reaffirmed at Buy with $60 Target | DTIL Stock News - GuruFocus
Precision BioSciences: Q1 Earnings Snapshot - CT Insider
Precision BioSciences Reports Q1 2025 Financial Results - TipRanks
Transcript : Precision BioSciences, Inc.Special Call - marketscreener.com
Precision BioSciences Inc Reports Q1 2025 EPS of $(2.21) and Rev - GuruFocus
1.74%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):